Otis Brawley, M.D.

Otis Brawley, M.D.

DirectoratLyell Immunopharma· In proxies 2023–2025

Otis Brawley, M.D. sits on 4 public boards.

Boards1

  • Lyell ImmunopharmaDirector · 3 yr on the boardIndependentNominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Lyell ImmunopharmaPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -80%
  2. Agilent TechnologiesPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  3. Incyte CorporationPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. PDS Biotechnology CorporationPublic company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?